Ramji Shiven 4

What Happened Ramji Shiven, President of Products & Technology at Cellebrite DI Ltd. (CLBT), was granted 423,550 restricted share units (RSUs) on 2026-05-12. The grant is reported as an award/acquisition (code A) with an acquisition price of $0.00 (typical for RSU compensation). Each RSU is a contingent right to receive one ordinary share of the company upon settlement; this is a compensation award rather than an open-market purchase or sale.

Key Details

• Transaction date: 2026-05-12; Form 4 filed 2026-05-14 (appears filed within the usual 2-business-day window).
• Amount: 423,550 RSUs granted; acquisition price reported as $0.00.
• Vesting schedule (per filing footnote): 105,898 RSUs vest on May 4, 2027; thereafter 26,471 RSUs vest every three months through May 4, 2030.
• Post-transaction holdings: Not specified in the summary filing details provided.
• Transaction code: A = Award/Grant; these RSUs are contingent and convert to shares only upon settlement/vesting.

Context RSU grants are standard executive compensation and do not represent an immediate purchase or sale of stock. Because these RSUs vest over multiple dates through 2030, they provide a long-term incentive tied to continued employment and/or performance rather than an immediate market position. For retail investors, awards signal management compensation alignment but are not a direct bullish or bearish trade by the insider.